{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02166489",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Royan-Kidney-003"
      },
      "Organization": {
        "OrgFullName": "Royan Institute",
        "OrgClass": "OTHER_GOV"
      },
      "BriefTitle": "Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease",
      "OfficialTitle": "Evaluation the Effect of Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Autosomal Dominant Polycystic Kidney Disease"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2015",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "March 2014"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 2015",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "January 2016",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "June 14, 2014",
      "StudyFirstSubmitQCDate": "June 17, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 18, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "January 3, 2016",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 5, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Royan Institute",
        "LeadSponsorClass": "OTHER_GOV"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "This study was designed to provide confirmation of safety of mesenchymal stem cells (MSCs) therapy in chronic renal failure due to autosomal dominant polycystic kidney disease (ADPKD).",
      "DetailedDescription": "The investigators will assess the 18-month safety and potential efficacy of autologous MSCs as therapy for ADPKD. A total of 6 patients with ADPKD IV injection of high doses 2Ã—106 of autologous mesenchymal stem cells / kg their weight, which will be derived from biopsies of their bone marrow. Assessments will be made at 1, 3, 6, 12 and 18 months after cell injection. Changes in GFR rate were evaluated by scan isotope."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Chronic Renal Failure",
          "Polycystic Kidney Disease"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "autologous mesenchymal stem cells",
          "polycystic kidney disease",
          "intravenous injection",
          "CRF"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "6",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "mesenchymal stem cell transplantation",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Intravenous injection of mesenchymal stem cell in patients with PKD",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Intravenous injection autologous mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Intravenous injection autologous mesenchymal stem cells",
            "InterventionDescription": "Intravenous injection of mesenchymal stem cell in patients with PKD",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "mesenchymal stem cell transplantation"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Mass formation",
            "PrimaryOutcomeDescription": "Evaluation the probability of mass formation in patients with PKD after mesenchyma l stem cell transplantation.",
            "PrimaryOutcomeTimeFrame": "1 month"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Glomerular Filtration Rate (GFR)",
            "SecondaryOutcomeDescription": "Evaluation the acceleration of Glomerular Filtration Rate (GFR) in patients after mesenchymal stem cell transplantation.",
            "SecondaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale and Female\nADPKD symptoms\nADPKD confirmed with sonography and genetic testing\nPatient's age between 18 - 60 years\nGFR GFR 25-60 mL/min/1.73 m2\nAbility to understand and willingness to sign consent from\n\nExclusion Criteria:\n\nPregnancy or breastfeeding\nAssociated Cardiovascular disease\nDiabetes requiring medical intervention\nOther systemic diseases involving the kidneys, such as cancer, autoimmune diseases, blood diseases, liver disease, etc.\nHospitalization due to illness in the last two months\nLife expectancy of less than two years\nAny allergies to the ingredients used in the cell culture",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "60 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Hamid Gourabi, PhD",
            "OverallOfficialAffiliation": "Head of Royan Institute",
            "OverallOfficialRole": "Study Chair"
          },
          {
            "OverallOfficialName": "Nasser Aghdami, MD,PhD",
            "OverallOfficialAffiliation": "Head of Department of Regenerative Medicine & Cell therapy center of Royan Institute",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Atieh Makhlough, MD",
            "OverallOfficialAffiliation": "Mazandaran University of Medical Sciences, Mazandaran, Iran.",
            "OverallOfficialRole": "Study Director"
          },
          {
            "OverallOfficialName": "Reza Moghadasali, PhD",
            "OverallOfficialAffiliation": "Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Royan Institute",
            "LocationCity": "Tehran",
            "LocationCountry": "Iran, Islamic Republic of"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "28535817",
            "ReferenceType": "derived",
            "ReferenceCitation": "Makhlough A, Shekarchian S, Moghadasali R, Einollahi B, Hosseini SE, Jaroughi N, Bolurieh T, Baharvand H, Aghdami N. Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients. Stem Cell Res Ther. 2017 May 23;8(1):116. doi: 10.1186/s13287-017-0557-7."
          }
        ]
      },
      "SeeAlsoLinkList": {
        "SeeAlsoLink": [
          {
            "SeeAlsoLinkLabel": "Related Info",
            "SeeAlsoLinkURL": "http://Royaninstitute.org"
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007674",
            "ConditionMeshTerm": "Kidney Diseases"
          },
          {
            "ConditionMeshId": "D000051437",
            "ConditionMeshTerm": "Renal Insufficiency"
          },
          {
            "ConditionMeshId": "D000007676",
            "ConditionMeshTerm": "Kidney Failure, Chronic"
          },
          {
            "ConditionMeshId": "D000051436",
            "ConditionMeshTerm": "Renal Insufficiency, Chronic"
          },
          {
            "ConditionMeshId": "D000007690",
            "ConditionMeshTerm": "Polycystic Kidney Diseases"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000014570",
            "ConditionAncestorTerm": "Urologic Diseases"
          },
          {
            "ConditionAncestorId": "D000052177",
            "ConditionAncestorTerm": "Kidney Diseases, Cystic"
          },
          {
            "ConditionAncestorId": "D000000015",
            "ConditionAncestorTerm": "Abnormalities, Multiple"
          },
          {
            "ConditionAncestorId": "D000000013",
            "ConditionAncestorTerm": "Congenital Abnormalities"
          },
          {
            "ConditionAncestorId": "D000072661",
            "ConditionAncestorTerm": "Ciliopathies"
          },
          {
            "ConditionAncestorId": "D000030342",
            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M25871",
            "ConditionBrowseLeafName": "Renal Insufficiency",
            "ConditionBrowseLeafAsFound": "Renal Failure",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9850",
            "ConditionBrowseLeafName": "Kidney Diseases",
            "ConditionBrowseLeafAsFound": "Kidney Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9864",
            "ConditionBrowseLeafName": "Polycystic Kidney Diseases",
            "ConditionBrowseLeafAsFound": "Polycystic Kidney Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18389",
            "ConditionBrowseLeafName": "Polycystic Kidney, Autosomal Dominant",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9851",
            "ConditionBrowseLeafName": "Kidney Failure, Chronic",
            "ConditionBrowseLeafAsFound": "Chronic Renal Failure",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M25870",
            "ConditionBrowseLeafName": "Renal Insufficiency, Chronic",
            "ConditionBrowseLeafAsFound": "Chronic Renal Failure",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M16471",
            "ConditionBrowseLeafName": "Urologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M26136",
            "ConditionBrowseLeafName": "Kidney Diseases, Cystic",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M12",
            "ConditionBrowseLeafName": "Congenital Abnormalities",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14",
            "ConditionBrowseLeafName": "Abnormalities, Multiple",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M1076",
            "ConditionBrowseLeafName": "Ciliopathies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T591",
            "ConditionBrowseLeafName": "Autosomal Dominant Multiple Pterygium Syndrome",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}